Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Articles

Jul 23 : CMS is warning against relying too heavily on EHR

cms

CMS: Don’t Over-Rely on EHR Decision Support Alerts

The Centers for Medicare and Medicaid Services is warning against relying too heavily on clinical decision support (CDS) “pop-up” alerts when meeting meaningful use Stage 2 objectives.

With the enormous amounts of patient data being generated from medical devices and electronic health records, CDS is seen as a linchpin for enabling the effective use of all of this information. As medical data and individual patient information become more readily available electronically, CDS is meant to improve quality of care and enhance outcomes by avoiding errors and adverse events, improving efficiencies, reducing costs, while enhancing provider and patient satisfaction.

“This is one of the main drivers for the popularity of CDS. For the next stage of meaningful use, healthcare providers using electronic health records will need to incorporate more and more CDS into their software to qualify for incentive payments,” says Bradley Merrill Thompson, general counsel for the CDS Coalition, which represents software providers, healthcare payers, providers and medical device manufacturers.

According to the Centers for Medicare and Medicaid Services, in Stage 1 of meaningful use eligible professionals and hospitals must implement one CDS rule. However, in Stage 2, EPs and EHs must implement five CDS interventions related to four or more clinical quality measures and implement functionality for drug-drug and drug-allergy interaction.

CMS advises that CDS can be provided in several ways, including interruptive activities such as “pop-up” alerts, information displays or links (such as InfoButton), and targeted highlighting of relevant data. “While many providers may associate CDS with pop-up alerts, alerts are not the only or necessarily the best method of providing support,” according to new guidance. “For example, a pop-up alert can only fire ‘after’ an event has occurred (e.g., a provider has ordered a contraindicated medication).” Given that “pop-up” alerts are not always effective for improving outcomes, CMS encourages the use of CDS interventions that are not “pop-up” oriented.

“Although the trigger intervention certification criteria require EHR technology to produce an alert at relevant points during patient care, the meaningful use objectives give providers flexibility in the types of CDS interventions they employ, and do not limit them to ‘pop-up’ alert interventions,” states CMS in the guidance on CDS interventions. “Providers can meet the objectives by using other kinds of CDS, including, but not limited to: clinical guidelines, condition-specific order sets, focused patient data reports and summaries, documentation templates, diagnostic support, and contextually relevant reference information.”

The key, CMS asserts, is that the information be presented when relevant, to those who can act on the information, and in a way that supports completion of the right action.

For more information, click on CMS’ recently updated Clinical Decision Support tipsheet and a new FAQ.

Source